Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population.

Tice JA, Miike R, Adduci K, Petrakis NL, King E, Wrensch MR.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):324-8.

2.

Patient variables that predict atypical cytology by nipple duct lavage.

Bushnaq ZI, Ashfaq R, Leitch AM, Euhus D.

Cancer. 2007 Apr 1;109(7):1247-54.

3.

The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.

Visvanathan K, Santor D, Ali SZ, Brewster A, Arnold A, Armstrong DK, Davidson NE, Helzlsouer KJ.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):950-5.

4.

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.

Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA.

J Natl Cancer Inst. 2001 Mar 7;93(5):358-66.

PMID:
11238697
5.

Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model.

Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Kamel S, Zeiger S, Mayo MS.

J Natl Cancer Inst. 2000 Aug 2;92(15):1217-27.

PMID:
10922407
6.

Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.

Higgins SA, Matloff ET, Rimm DL, Dziura J, Haffty BG, King BL.

Breast Cancer Res. 2005;7(6):R1017-22. Epub 2005 Oct 24.

7.

Nipple aspirate fluid cytology in breast carcinoma.

Krishnamurthy S, Sneige N, Thompson PA, Marcy SM, Singletary SE, Cristofanilli M, Hunt KK, Kuerer HM.

Cancer. 2003 Apr 25;99(2):97-104.

8.

Nipple aspirate fluid color is associated with breast cancer.

Sauter ER, Winn JN, Dale PS, Wagner-Mann C.

Cancer Detect Prev. 2006;30(4):322-8. Epub 2006 Sep 11.

PMID:
16963197
9.

Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study.

Buehring GC, Letscher A, McGirr KM, Khandhar S, Che LH, Nguyen CT, Hackett AJ.

Breast Cancer Res Treat. 2006 Jul;98(1):63-70. Epub 2006 May 10.

PMID:
16685591
10.

Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid.

Wrensch MR, Petrakis NL, Miike R, King EB, Chew K, Neuhaus J, Lee MM, Rhys M.

J Natl Cancer Inst. 2001 Dec 5;93(23):1791-8.

PMID:
11734595
11.

Gail model risk factors: impact of adding an extended family history for breast cancer.

Crispo A, D'Aiuto G, De Marco M, Rinaldo M, Grimaldi M, Capasso I, Amore A, Bosetti C, La Vecchia C, Montella M.

Breast J. 2008 May-Jun;14(3):221-7. doi: 10.1111/j.1524-4741.2008.00566.x. Epub 2008 Mar 26.

PMID:
18373641
12.

Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid.

Wrensch MR, Petrakis NL, King EB, Miike R, Mason L, Chew KL, Lee MM, Ernster VL, Hilton JF, Schweitzer R, et al.

Am J Epidemiol. 1992 Jan 15;135(2):130-41.

PMID:
1536131
13.

Predicting risk of breast cancer in postmenopausal women by hormone receptor status.

Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA; Women's Health Initiative Investigators.

J Natl Cancer Inst. 2007 Nov 21;99(22):1695-705. Epub 2007 Nov 13.

PMID:
18000216
14.

Prostate-specific antigen production in the female breast: association with progesterone.

Sauter ER, Babb J, Daly M, Engstrom PF, Ehya H, Malick J, Diamandis E.

Cancer Epidemiol Biomarkers Prev. 1998 Apr;7(4):315-20.

15.

Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk.

Sauter ER, Ross E, Daly M, Klein-Szanto A, Engstrom PF, Sorling A, Malick J, Ehya H.

Br J Cancer. 1997;76(4):494-501.

16.

C-reactive protein in nipple aspirate fluid associated with Gail model factors.

Lithgow D, Nyamathi A, Elashoff D, Martinez-Maza O, Covington C.

Biol Res Nurs. 2007 Oct;9(2):108-16.

17.

Proliferative epithelial disease identified in nipple aspirate fluid and risk of developing breast cancer: a systematic review.

Hornberger J, Chen SC, Li Q, Kakad P, Quay SC.

Curr Med Res Opin. 2015 Feb;31(2):253-62. doi: 10.1185/03007995.2014.988209. Epub 2014 Dec 3. Review.

PMID:
25405383
18.

Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size.

Sauter ER, Ehya H, Babb J, Diamandis E, Daly M, Klein-Szanto A, Sigurdson E, Hoffman J, Malick J, Engstrom PF.

Br J Cancer. 1999 Dec;81(7):1222-7.

19.
20.

Breast cancer risk assessment in indigent women at a public hospital.

Abu-Rustum NR, Herbolsheimer H.

Gynecol Oncol. 2001 May;81(2):287-90.

PMID:
11330964

Supplemental Content

Support Center